Singh Bijay, Choi Yun-Jaie, Park In-Kyu, Akaike Toshihiro, Cho Chong-Su
J Nanosci Nanotechnol. 2014 Jan;14(1):564-76. doi: 10.1166/jnn.2014.9079.
Successful gene therapy depends on the development of efficient and cell-specific gene delivery systems. Currently, animal viral vectors have been mostly used for in vivo and in clinical trials owing to their high transduction efficiency. However, they suffer from numerous limitations such as biosafety, immunogenicity, gene packaging capacity, complicated production and cell specificity. Therefore non-viral vectors are attractive alternatives to viral gene delivery systems due to their low toxicity, relatively easy production and greater diversity. Among non-viral vectors, chitosan and chitosan derivatives have been extensively utilized as gene carriers owing to their low immunogenicity, biocompatibility, biodegradability, low toxicity and ease of chemical modifications. However, low transfection efficiency of DNA (or low gene silencing of siRNA) and low cell specificity of chitosan should be overcome before clinical trials. The objective of this review is to summarize several parameters affecting the transfection efficiency of DNA (or gene silencing of siRNA) for the promising use of chitosan as gene carriers. Besides, chemical modifications of chitosan with pH-sensitive molecules and specific ligands so as to enhance the transfection efficiency of DNA (or gene silencing of siRNA) and cell specificity will be covered.
成功的基因治疗依赖于高效且细胞特异性的基因递送系统的开发。目前,动物病毒载体因其高转导效率而大多用于体内研究和临床试验。然而,它们存在诸多局限性,如生物安全性、免疫原性、基因包装能力、生产复杂以及细胞特异性等问题。因此,非病毒载体因其低毒性、相对容易生产和更高的多样性,成为病毒基因递送系统有吸引力的替代方案。在非病毒载体中,壳聚糖及其衍生物因其低免疫原性、生物相容性、可生物降解性、低毒性以及易于化学修饰等特性,已被广泛用作基因载体。然而,在进行临床试验之前,需克服壳聚糖转染DNA效率低(或siRNA基因沉默效率低)以及细胞特异性低的问题。本综述的目的是总结影响壳聚糖作为基因载体有效转染DNA(或siRNA基因沉默)的几个参数。此外,还将探讨壳聚糖与pH敏感分子和特异性配体的化学修饰,以提高DNA转染效率(或siRNA基因沉默效率)和细胞特异性。